#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary biliary cholangitis Hepatitis B Oesophageal atresia Antithrombin III deficiency Ovarian cancer C3 glomerulopathy Iron overload Marginal zone lymphoma refractory CDKL5 deficiency disorder Hyperoxaluria Warm autoimmune haemolytic anaemia Metastases to central nervous system Mantle cell lymphoma stage IV Hypertriglyceridaemia Mucopolysaccharidosis I More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Diagnostics Urea cycle disorder – Diagnostics Metachromatic leukodystrophy – Life with Disease Toxic epidermal necrolysis – Treatment Hyperoxaluria – Basic Information Retinitis pigmentosa – Trials in Disease Gaucher’s disease type I – Treatment Retinitis pigmentosa – Basic Information Ehlers-Danlos syndrome – Trials in Disease Leiomyosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ABBV-8736 Tinengotinib Lidocaine Hydrochloride Av-Ec2023 Peboctocogene Camaparvovec Amphotericin B ALE.P03 INSULIN DEGLUDEC SODIUM SELENITE PENTAHYDRATE Dapirolizumab Pegol Anhydrous Docetaxel Safinamide Telmisartan Desloratadine Adenosine Vincristine Losartan Potassium Oxaliplatin Evolocumab Triamcinolone Hexacetonide More therapies…

    Learn about Your Condition

    Meniscus operation Peritoneal abscess Diabetic autonomic neuropathy Progressive multiple sclerosis Pathogen resistance Metastases to lymph nodes Weaning failure Cardiac failure acute Facial paresis CDKL5 deficiency disorder Acute respiratory failure Osteoporosis postmenopausal Atrial septal defect Compulsive sexual behaviour Bone metabolism disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Vitamin D for Patients with Depression or Bipolar Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    • Depression
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Study on Sevoflurane and Propofol for Heart Protection in Double Valve Surgery Patients

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • Propofol
    Spain

  • Study on Verapamil and Exenatide for Adults with Type 1 Diabetes to Measure Changes in Beta Cell Mass

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Exenatide
    • Verapamil
    Austria France

  • Study on Using Copper (64Cu) Chloride PET/CT Imaging for Prostate Cancer Patients with Biochemical Relapse After Surgery to Guide Radiation Therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Copper (64Cu) Chloride
    Italy

  • Study on Pembrolizumab and Drug Combination for Patients with Localized Colon Cancer with Specific Genetic Markers

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Oxaliplatin
    France

  • Study on the Effectiveness of Telitacicept for Adults with Moderate to Severe Systemic Lupus Erythematosus

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Telitacicept
    Croatia France Greece Italy Poland Romania
Previous Page
1 … 838 839 840 841 842 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!